The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 928-932

  Zhang, Ming Sheng ^a   Hu, Ai Hua ^a   Qiu, Hong ^a   Xiong, Hui Hua ^a   Chen, Yuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Bcl 2; Colorectal adenocarcinoma; Expression; IGF II

Indexed keywords

CYCLINE; MESSENGER RNA; PROTEIN BCL 2; SOMATOMEDIN B; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION; GROUPS BY AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME; ADENOCARCINOMA; CANCER INVASION; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FOLLOW UP; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; COLON; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; INSULIN-LIKE GROWTH FACTOR II; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84863795545     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9881-4     Document Type: Article

References (24)

1. Tang DQ. Modern oncology. 2nd ed. Shang Hai: The Press of Shang Hai Medical University; 2000 p. 121.
2. Lee AV, Darbre P, King RJ. Processing of insulin-like growth factor-II(IGF-II) by human breast cancer cells. Mol Cell Endocrinol. 1994;99:211-20.
3. Singh SK, Moretta D, Almaguel F, De León M, De León DD. Precursor IGF-II (proIGF-II) and mature IGF-II (mIGF-II) induce Bcl-2 and Bcl-X L expression through different signaling pathways in breast cancer cells. Growth Factors. 2008;26:92-103.
4. Cariani E, et al. Differential expression of insulin-like growth factor-IImRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res. 1988;48:6844-9.
5. Kalla Singh S, et al. Differential insulin-like growth factor II (IGF-II) expression: a potential role for breast cancer survival disparity. Growth Horm IGF Res. 2010;20:162-70.
6. Höppener JW, et al. Expression of insulin-like growth factor-I and -II renes in human smooth muscle tumors. EMBO J. 1988;7:1379-85.
7. Tricoli JV, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 1986;46:6169-6173.
8. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer. 1992;65:311-20.
9. Peng NM, Wang ZL. The basis and clinic of cell apoptosis.1st ed. Beijing: The Press of People Health; 2000. p. 251-252.
10. Mohan S, Jennings JC, Linkhart TA, Baylink DJ. Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biohim Biophys Acta. 1988;966: 44-55.
11. Berger Abi. Insulin-like growth factor and cognitive function. BMJ. 2001; 322:203.
12. McKeithan TW, Rowley JD, Shows TB, Diaz MO. Cloning of the chromosome breakpoint of neoplastic B cells with the t (14, 18) chromosometranslocation. Science. 1984;226:1097-9.
13. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;384:334-6.
14. Freier S, et al. Expression of the insulin-like growth factors and their receptors in adenocarinoma of the colon. Gut. 1999;44: 704-8.
15. Ishijima N, Miki C, Ishida T, Kinoshita T, Suzuki H. The Immunohistochemical expression of Bcl-2 oncoprotein in colorectal carcinoma. Surg Today. 1999;29:682-4.
16. Evertsson S, Bartik Z, Zhang H, Jansson A, Sun XF. Apoptosis in relation to proliferating cell nuclear antigen and Dukes0stage in colorectal adenocarcinoma. Int J Oncol. 1999;15:53-8.
17. Zheng E. Mechanism of carcinoma. 1st ed. Beijing: The Press of BeiJing; 1999. p. 189-194.
18. Rohlik QT, Adams D, Kull FC Jr, Jacobs S. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun. 1987;149:276-81.
19. Huang GS, et al. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer. Clin Cancer Res. 2010;16:2999-3010.
20. Hassan AB, Macaulay VM. The insulin-like growth factor system as a therapeutic target in colorectal cancer. Ann Oncol. 2002;13: 349-56.
21. Avnet S, et al. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Res. 2009;69:2443-52.
22. Yang DH, et al. Inhibitory effect of IGF-II antisense RNA on malignant phenotype of hepatocellular carcinoma. World J Gastroenterol. 2000;6:266-7.
23. Kawamoto K, et al. Expression of insulin-like growth factor-IIcan predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology. 1998;55:242-8.
24. Leahy DT, Mulcahy HE, O'Donoghue DP, Parfrey NA. Bcl-2 protein expression is associatated with better prognosis in colorectal cancer. Histopathology. 1999;35:360-7.